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Abstract
 
Nuclear factor of activated T cells (NFAT) transcription factors regulate gene expression in
lymphocytes and control cardiac valve formation. Here, we report that NFATp regulates
chondrogenesis in the adult animal. In mice lacking NFATp, resident cells in the extraarticular
connective tissues spontaneously differentiate to cartilage. These cartilage cells progressively
 
differentiate and the tissue undergoes endochondral ossification, recapitulating the development
of endochondral bone. Proliferation of already existing articular cartilage cells also occurs in
some older animals. At both sites, neoplastic changes in the cartilage cells occur. Consistent
with these data, NFATp expression is regulated in mesenchymal stem cells induced to differen-
tiate along a chondrogenic pathway. Lack of NFATp in articular cartilage cells results in increased
expression of cartilage markers, whereas overexpression of NFATp in cartilage cell lines extin-
guishes the cartilage phenotype. Thus, NFATp is a repressor of cartilage cell growth and differen-
tiation and also has the properties of a tumor suppressor.
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Introduction
 
Nuclear factor of activated T cells (NFAT)
 
1
 
 is a family of tran-
scription factors critical in regulating early gene transcription in
response to T cell receptor–mediated signals in lymphocytes
(1–6). There are currently four known NFAT genes, NFATp
(NFATc2, NFAT1), NFATc (NFATc1, NFAT2), NFAT3
(NFATc4), and NFAT4 (NFATc3, NFATx) (7–11), that
share homology within a region distantly related to the Rel
domain. As described below, evidence is emerging that this
family of transcription factors controls processes of cell dif-
ferentiation, likely in response to changes in calcium flux,
in progenitor cells of multiple lineages.
In resting T cells, NFAT proteins are present in the cyto-
plasm as phosphorylated species. Upon activation, sustained
increases in calcium activate the phosphatase calcineurin,
which subsequently dephosphorylates NFAT (12–14), which
is then quickly translocated into the nucleus to drive gene
expression in association with other factors such as c-Maf, ac-
tivator protein 1 (AP-1), and NFAT-interacting protein 45
(NIP45) (15–18). Dephosphorylated NFAT is then rephos-
phorylated on serine residues by glycogen synthase kinase 3
(GSK3) and translocated back to the cytoplasm (19). The
activation-dependent dephosphorylation and translocation
of NFAT in lymphocytes and in cardiac endothelial and
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 BMP, bone morphogenetic protein;
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muscle cells can be blocked by immunosuppressive drugs
such as cyclosporin A or tacrolimus (FK506), which block
calcineurin (20).
Much has been learned about the function of NFAT
proteins from the generation of NFAT genetic mutant mouse
strains. Mice lacking NFATc die in utero from failure to form
the semilunar cardiac valves (5, 6), and a role for NFAT3 in
cardiac hypertrophy has been elegantly demonstrated (21).
T cells from mice lacking NFATc in the lymphoid system
(as evaluated by recombination activating gene [RAG]-2
blastocyst complementation) hypoproliferate and have im-
paired IL-4 production (22, 23), consistent with a function
of NFATc as a direct transcriptional activator of the IL-4
gene. Recently, NFATc has also been shown to regulate
HIV-1 replication in T cells (24). Evidence that NFATp
and NFAT4 might repress proliferative responses, Th2 cell
formation, and lymphocyte activation was obtained from the
characterization of NFATp and NFAT4 single and double
deficient animals. Mice lacking NFAT4 have normal pe-
ripheral T cell proliferation and cytokine production, although
there is an increase in the number of memory and/or acti-
vated T and B cells (25). We and others have previously
described the phenotype of mice lacking NFATp (26–28).
Such animals display modest splenomegaly with hyperpro-
liferation of T and B lymphocytes and enhanced Th2 re-
sponses as measured by increased IL-4 and IgE production.
Mice lacking both NFATp and NFAT4 have massive lym-
phoproliferation and selective activation of the Th2 com-
partment (29).
The widespread distribution of NFATp in the adult animal
suggested that this family member might control cellular dif-
ferentiation programs in organ systems unrelated to the im-
mune system, and indeed recent evidence suggests that
NFATp may participate in processes of adipogenesis and
myogenesis (30, 31). Here, we demonstrate that NFATp is a
potent repressor of cartilage cell growth and differentiation in
the adult animal. Few molecular regulators of chondrogenesis
have been identified, and the majority of these affect the em-
bryonic formation of cartilage. To our knowledge, NFATp is
the first transcription factor described to control the differen-
tiation of adult mesenchymal stem cells (MSCs) into cartilage.
Mice lacking NFATp should prove valuable for the study of
cell lineage commitment decisions in chondrogenesis. Fur-
ther, the potential use of NFATp inhibitors in degenerative
and inflammatory joint diseases such as osteoarthritis and
rheumatoid arthritis, where cartilage has been destroyed, and
in the stimulation of endochondral bone formation to achieve
repair of bone defects and fractures, is obvious.
 
Materials and Methods
 
Mice.
 
NFATp
 
2
 
/
 
2
 
 mice were generated as described (5, 26)
and have been backcrossed onto a BALB/c background for at
least eight generations. Wild-type (wt) controls were 
 
1
 
/
 
1
 
 or 
 
1
 
/
 
2
 
littermates. Mice were housed in sterilized microisolator cages,
fed autoclaved food and water, and handled in laminar airflow
hoods. All animal studies were approved by the Harvard Univer-
sity Institutional Review Board.
 
Light Microscopic Analysis.
 
For paraffin sections, bone specimens
were fixed in 10% buffered formalin (0.1 M PBS, pH 7.4) for 2 wk,
decalcified in 25% formic acid for 2–3 wk, processed and embed-
ded in paraffin, cut into 6-
 
m
 
m sections, and stained with hema-
toxylin and eosin or safranin O–fast green. For plastic-embedded
sections, bones were fixed and decalcified as above and infiltrated
for 2–3 wk before embedding in JB4 medium (Polysciences) and
sectioned at 4.5-
 
m
 
m thickness (32). They were stained with 0.5%
toluidine blue or safranin O–fast green.
 
Preparation of Cartilage Cells and Cell Lines, and Stable Transfec-
tion of the S12 and Extraarticular Cartilage Cell Lines.
 
Hind limbs of
normal and NFATp
 
2
 
/
 
2
 
 and NFATp
 
1
 
/
 
2
 
 mutant mice were dissected
from the torso leaving the femoral joint intact. The femoral head
was isolated from the joint, and the articular surface was cut upwards
from the neck of the femur. The articular cap was released by
producing a small incision through the femoral head and applying
pressure with a pair of forceps to release the secondary center of
ossification containing trabecular bone. Cells within the articular
cartilage that had been cleanly removed free of the underlying
trabecular bone or cells from physically distinct masses in the ex-
traarticular soft tissues (EA cells) were dissociated by digestion of
the tissue with trypsin/collagenase (33) for 6 h. Cells were plated
at a density of 2.5 
 
3
 
 10
 
5
 
/100-mm dish and grown in DMEM/10%
fetal bovine serum until reaching confluence at 2–3 wk. Cells
were trypsinized and replated at 2 
 
3
 
 10
 
6
 
/100-mm dish. All ex-
periments depicted in these studies are from second passage pri-
mary cells.
To generate the S12 cell line, rapidly dividing cultures of
NFATp
 
2
 
/
 
2
 
 primary cells that had reached confluence were sub-
cloned by limiting dilution (1,000 cells/100-mm dish) and al-
lowed to grow until separate colonies could be visualized. Colo-
nies were picked with cloning discs (Scienceware
 
®
 
; Bel-Art
Products) and expanded to establish multiple clonal lines. One such
line, S12, was chosen for further study. Stable transfection of S12
and of a bulk population of EA cells was achieved by electropora-
tion at 250 V, 975 
 
m
 
F of 5 
 
3 
 
10
 
6
 
 S12 or EA cells in 400 
 
m
 
l RPMI
1640 medium without supplements containing 20 
 
m
 
g of an
NFATp expression plasmid in the vector pRep4, or empty vector
alone. Selection with hygromycin at 25–50 
 
m
 
g/ml resulted in the
appearance of hygromycin-resistant colonies in 
 
z
 
2 wk.
 
Immunohistochemistry Analysis.
 
Immunofluorescent staining was
carried out with antibodies to type II collagen (PF4Z; Caltag) and
cartilage oligomeric protein (COMP), provided by Dr. D. Heine-
gard (Lund University, Lund, Sweden). Immunoreactions were car-
ried out as reported previously using culture pretreatment with
monensin to enhance cellular staining of secreted proteins (34).
Both phase–contrast and immunofluorescent photomicroscopy
were performed using an OM-2 microscope (Olympus Co.) on
T-Max
 
®
 
 p3200 film (Eastman Kodak Co.).
 
Reverse Transcription PCR, and Northern and Western Blot Analysis.
 
RNA was prepared from wt and NFATp
 
2
 
/
 
2
 
 cartilage cultures
and from S12 and EA transfected cell lines. Reverse transcription
(RT)-PCR was performed using primers specific for NFATp
(upper, 5
 
9
 
-tctccaatcagtcgggctcctatg; lower, 5
 
9
 
-gctcggggcagtctgt-
tgttgg), NFATc (upper, 5
 
9
 
-tccggcgcatgcgagccgtcatcgactgtgctgggat-
cctga; lower, 5
 
9
 
-ggacccgggtcaattggcaggaaggtacgtgaaacg), NFAT4
(upper, 5
 
9
 
-cttccccagcagcctctcatcc; lower, 5
 
9
 
-ccgtggtgggcaaaaggct-
cagtg), NFAT3 (upper, 5
 
9
 
-gaagctaccctccggtacagag; lower, 5
 
9
 
-gct-
tcatagctggctgtagcc), type II collagen (upper, 5
 
9
 
-cctgtctgcttcttgtaaaac;
lower, 5
 
9
 
-acagaggtgtttgacacag), type X collagen (upper, 5
 
9
 
-cttct-
caggattcctagtggc; lower, 5
 
9
 
-gagccattgagtgatgcacc), cartilage-derived
morphogenetic protein (CDMP)-1 (growth/differentiation factor
[GDF]5) (upper, 5
 
9
 
-acgggacctgttctttaatg; lower, 5
 
9
 
-cttatacaccac- 
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gttgttgg), 
 
b
 
-actin (upper, 5
 
9
 
-ctggagaagagctatgagct; lower, 5
 
9
 
-gcc-
atgccaatgttgtctct), and hypoxanthine phosphoribosyltransferase
(HPRT) (33, 35–37). All RT-PCR was carried out using 1 
 
m
 
g of
total mRNA using a Titan™ One Tube kit (Boehringer Mann-
heim) according to the manufacturer’s instructions. Individual salt
and primer annealing temperatures were determined for each
primer set. For semiquantitative RT-PCR, initial RT reactions
were carried out followed by sequential amplification for five cycles.
The resultant cDNAs were then diluted serially 3 times, and PCR
was carried out for 24 cycles. Amplicons from control reactions
carried out with mRNA isolated from articular cartilage were
confirmed by sequence analysis. The products were resolved on a
1.4% agarose gel, stained with GelStar
 
®
 
, and individual band in-
tensities were determined using an Alpha Innotech Image Analy-
sis system. The slopes of the titration curves normalized to that of
 
b
 
-actin were used as a relative approximation of the individual
mRNA quantities.
For Northern blot analysis, 10 
 
m
 
g of RNA was fractionated by
electrophoresis on 1.2% agarose/6% formaldehyde gels. Identical
gels were blotted to Gene Screen and hybridized with at least 1 
 
3
 
10
 
6
 
 cpm of random primer–labeled cDNA fragments per millili-
ter of QuikHyb
 
®
 
 solution according to the manufacturer’s in-
structions (Stratagene). cDNA fragments were purified from plas-
mids TGF-
 
b
 
1,2,3 (gift of J. Letterio, National Institutes of
Health, Bethesda, MD) and GDF5,6 (gift of S. Lee, Johns Hop-
kins Medical School, Baltimore, MD). Nuclear and cytoplasmic
extracts for Western blot analysis were prepared from S12 and EA
NFATp transfectants. Nuclei were isolated as described (38). Ex-
tracted proteins were separated by 8% PAGE followed by elec-
trotransfer to nitrocellulose membranes and probed with an mAb
specific for NFATp (Santa Cruz Biotechnology) followed by horse-
radish peroxidase–conjugated goat anti–mouse IgG and enhanced
chemiluminescence according to the instructions of the manufac-
turer (Amersham Pharmacia Biotech).
 
Proliferation Assays.
 
Wt cartilage cells and NFATp
 
2
 
/
 
2
 
 cartilage
cells were plated at varying densities in triplicate in 96-well mi-
crotiter plates for 48 h and pulsed with [
 
3
 
H]thymidine 16 h be-
fore harvesting to measure incorporation into DNA.
 
Karyotypic Analysis and Generation of Cartilage Cells from MSCs
In Vitro.
 
Karyotypic analysis was performed by K. Au (Diagnos-
tic Cytogenetics, Inc., Seattle, WA). The human and mouse
MSCs were provided by Drs. A. Caplan and J. Dennis (Case
Western Reserve Medical School, Cleveland, OH) and generated
as described (39, 40). Chondrogenesis was induced by culturing
human MSCs in micromass pellets in the presence of a defined
medium that includes dexamethasone and TGF-
 
b
 
3 (40–45).
 
Results
 
Skeletal Abnormalities in Mice Lacking NFATp.
 
We have
previously described the generation and immune system
phenotype of mice with a targeted disruption at the NFATp
locus (26). These mice express reduced amounts of a mu-
tant NFATp protein that fails to bind DNA. Hence, we re-
fer to these mice as NFATp
 
2
 
/
 
2
 
. NFATp
 
2
 
/
 
2
 
 mice appeared
healthy and were fertile, and the development of the skele-
tal system was normal. However, after 
 
z
 
6 mo of age, the
animals developed progressive difficulty in ambulation ac-
companied by fixed contractures and a significantly decreased
range of joint motion. The phenotype persisted upon mul-
tiple backcrosses of the disrupted NFATp locus to the
 
BALB/c strain. All affected animals had involvement of the
hip joints, and in some female mice, similar changes were
also observed in other peripheral joints such as the shoul-
der, knee, and ankle. The phenotype affected 100% of fe-
males and approximately one third of males, and symptoms
occurred earlier and were much more severe in female ani-
mals. Radiograms (Fig. 1) revealed extensive joint destruc-
tion and the deposition of extraarticular calcified masses
that proved to be cartilage and bone by light microscopy.
No abnormalities were noted in the axial skeleton.
 
Recapitulation of Endochondral Bone Formation in NFATp
 
2
 
/
 
2
 
Connective Tissue.
 
Skeletal morphogenesis of long bones
occurs when undifferentiated MSCs differentiate into chon-
droblasts that synthesize a cartilage matrix. The central por-
tion of this cartilaginous matrix is resorbed to form the
marrow cavity (cavitation). The more superficial cartilage
cells at the ends of the long bones further differentiate and
synthesize the matrix components of the surface and super-
ficial layers of the true articular cartilage. A second group of
cartilage cells distally also proliferates and undergoes a pro-
gressive differentiation and synthesis of a matrix, which cal-
cifies and is ultimately resorbed and replaced by osteoblasts
to form bone (endochondral ossification).
In NFATp
 
2
 
/
 
2
 
 mice, visual inspection of the hip joint re-
vealed abnormalities of the articular cartilage and also re-
vealed extraarticular masses of cartilage that not only were
spatially distinct from one another in the extraarticular soft
tissues but also were easily separable manually from the joint.
The articular cartilage in NFATp
 
2
 
/
 
2
 
 mice was grayish in
color compared with wt littermates and had a visibly rough-
ened surface in contrast to the smooth, polished appearance
of the wt control articular cartilage. Both gross analysis and a
careful longitudinal histologic analysis were performed on
many animals, ranging in age from 2.5–20 mo, and represen-
tative sections are shown in Fig. 2. Light microscopic analysis
Figure 1. Cartilage masses and joint destruction in NFATp2/2 mice. X
ray of a severely affected 20-mo-old NFATp2/2 female (left) and a 1/1
female littermate (right). Multiple calcified masses in the shoulder, knee,
hip, and ankle joints and joint destruction are present. X-OMAT Diag-
nostic film (Eastman Kodak, Inc.) was used, and the exposure time was set
at 50 s, 20 kV. 
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demonstrated proliferation of abnormal-looking cartilage
cells in the articular cartilage (Fig. 2, A and B), most apparent
in older female animals. When this proliferation occurred, it
was apparent in the layer of already existing cartilage cells
above the zone of calcified cartilage (Fig. 2, A–C). In the
most severe cases, as in the 1-yr-old animal shown, there was
extensive degradation of the cartilage and destruction of the
joint (Fig. 2, B and C).
In all NFATp
 
2
 
/
 
2 
 
female mice, ectopic formation of car-
tilage occurred in the extraarticular soft tissues. In extraar-
ticular connective tissue, resident cells rapidly differentiated
to safranin-O staining cartilage cells beginning as early as 3 mo
of age. Multiple, spatially distinct sites of cartilage formation
were formed with time, accompanied by progressive endo-
chondral differentiation of the cartilage cells, columnar ar-
rangement of the tissue, invasion of the cartilage tissue by
Figure 2. Cartilage cell proliferation in
articular cartilage and in extraarticular con-
nective tissue in NFATp2/2 mice. (A and
B) Low power (original magnification:
320) of the femoral heads and acetabula of
12-mo-old control 1/2 (A) and NFATp2/2
mutant (B) mice, showing thickening of
articular cartilage and sites of extraarticular
cartilage cell proliferation and joint destruc-
tion in the mutant animal. (C) High power
(original magnification: 3200) of B, show-
ing invasion of the acetabulum by prolifer-
ating cartilage cells (black arrows) and oblit-
eration of the joint space (white arrows)
with loss of safranin-O staining (*). (D)
Femoral head and extraarticular connective
tissues of 3-mo-old NFATp2/2  mouse
(original magnification: 3100), clearly
demonstrating the physical separation of the
sites of articular and extraarticular cartilage
proliferation. (E) Extraarticular connective
tissues of 3-mo-old NFATp2/2 mouse
demonstrating the differentiation of resident
cells into ordered columnar cartilage (ar-
rows). (F) High power (original magnifica-
tion: 3200) of E. (G) Extraarticular con-
nective tissues of 6-mo-old NFATp2/2
mouse showing calcification of cartilage and
the beginnings of endochondral ossification
in the extraarticular soft tissue (original
magnification:  3200). ac, articular cartilage;
fh, femoral head; a, acetabulum; ea, extraar-
ticular; ob, osteoblasts; oc, osteocytes; cc,
calcified cartilage; b, bone. 
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capillaries and chondroclasts (osteoclasts), calcification of the
cartilage, and replacement of cartilage by bone synthesized
by osteoblasts (endochondral ossification) (Fig. 2, D–G).
Thus, at 3 mo of age, induction of chondrogenesis in the
extraarticular soft tissues occurred with resident cells in the
extraarticular soft tissue beginning to differentiate into car-
tilage and align into typical columnar fashion (Fig. 2, D–F).
At 6 mo of age, sequential differentiation of the chondrocytes
and the onset of endochondral ossification were apparent
(Fig. 2 G). From 3 to 20 mo, there was a steady and pro-
gressive increase in the volume of cartilage and bone in the
individual extraarticular masses as the process of endochon-
dral bone formation continued, as well as the initiation of
new sites of cartilage induction (Fig. 2, D–G). The uncon-
trolled induction, proliferation, and differentiation of the
resident extraarticular connective tissue cells over the 20-mo
period studied also extended into and between the fibers of
the overlying muscle layers (Fig. 2, B and C).
Proliferation of NFATp2/2 Cartilage Cells Is Cell Intrinsic.
One explanation for this phenotype is induction of uncon-
trolled cartilage proliferation by an extrinsic factor(s). Alter-
natively, the dysregulation observed may be intrinsic to the
cartilage cell precursor. To determine whether these char-
acteristics were extrinsic or intrinsic to the cells, we more
carefully characterized their phenotype and behavior. Carti-
laginous tissue was removed from the surfaces of the femoral
and humeral heads and from the extraarticular cartilage
masses of affected NFATp2/2, control wt, and NFATp1/2
heterozygous mice and placed in culture. NFATp is widely
expressed in many adult tissues, but has not been described
to be present in cartilage. Examination by RT-PCR of RNA
prepared from cells from the cartilage cultures established
above did reveal the presence of transcripts encoding NFATp
in wt cartilage cells. Further, a mutant transcript correspond-
ing in size to the gene-targeted NFATp allele was detected
in the cells established from NFATp2/2 cartilage (Fig. 3 a).
Interestingly, transcripts specific for the three other NFAT
family members, NFATc, NFAT4, and NFAT3, were also
present in wt and NFATp2/2 cartilage (Fig. 3 a). Examina-
tion of the NFATp2/2 cultures revealed cuboidal cells that
grew in sheets (Fig. 3, b and c). Immunohistochemical anal-
ysis confirmed that a high percentage of cells expressed type
II collagen and COMP, antigens that are characteristic of dif-
ferentiated cartilage cells (Fig. 3, d and e). These results dem-
onstrated that differentiated cartilage cells expressed NFATp
as well as NFATc, NFAT4, and NFAT3, and that the prolif-
erating cells present in the articular and extraarticular cartilage
of NFATp2/2 animals were indeed of cartilage origin.
Cartilage cells from NFATp2/2 mice proliferated in cul-
ture, and in some instances displayed uncontrolled growth
consistent with malignant transformation (see below). A
variety of growth and differentiation factors has been shown
to cause induction and proliferation of cartilage cells from
primitive mesenchymal progenitor cells in vitro, and in some
instances, in vivo. Most notable among these are members
of the TGF-b family and the related bone morphogenetic
protein factors (BMPs), although the latter appear to be more
critical in skeletal morphogenesis than in mature cartilage
growth (46, 47). It was possible that NFATp negatively
regulated the transcription of one or more of these factors.
Therefore, we scanned the NFATp2/2 cartilage cell lines
for their expression of the TGF-b family members as well
as other genes most often thought to be involved in chondro-
genesis, and found normal or reduced levels of TGF-b1,
TGF-b2, TGF-b3, GDF5 (CDMP-1), GDF6 (CDMP-2),
and Sox9 (normal) transcripts compared with wt cartilage
cells (not shown). Thus, overexpression of these known
regulators of chondrogenesis does not appear to account for
the induction of proliferation and differentiation of con-
nective tissue precursor cells to cartilage cells or the prolif-
eration of articular cartilage cells observed in the absence of
NFATp in the adult animal. To further address the possi-
bility that these cellular events were driven by secreted fac-
tors, wt cartilage cells were cultured with supernatants de-
rived from the NFATp mutant cell lines. No effect on
proliferation of wt cartilage was observed (not shown). We
conclude that the uncontrolled induction and proliferation
of endochondral lineage cartilage cells and of the already
existing articular cartilage cells in the absence of NFATp
are likely to be intrinsic to the cell, although we cannot
rule out a secreted factor that requires other culture condi-
tions to be active.
NFAT Expression Is Regulated during Cartilage Cell Differ-
entiation. NFATp is not expressed in the skeletal system
during embryonic development at embryonic day (E)11
and E13.5 (not shown), and mice lacking NFATp display
Figure 3. Characteristics of cartilage cells
derived from NFATp2/2 cartilage. (a) RT-
PCR of RNA prepared from wt and
NFATp2/2 cartilage cells showing presence
of wt and mutant NFATp transcripts as well
as transcripts for NFATc, NFAT4, and
NFAT3. (b) Phase–contrast micrograph of
NFATp2/2 cartilage cells. (c) Immunohis-
tochemical analysis of the same field stained
with an antibody to type II collagen. (d)
Phase–contrast micrograph of NFATp2/2
cartilage cells. (e) The same field stained with
an antibody to COMP.14 NFATp Represses Chondrogenesis
normal skeletal morphogenesis. Further, we could not de-
tect NFATp protein in articular cartilage cells or in articu-
lar cartilage in vivo despite multiple attempts using Western
blot analysis, immunofluorescence, immunohistochemistry,
or labeling with immunogold on frozen or paraffin sections
of articular cartilage. We concluded that NFATp is present
at very low levels in differentiated cartilage, detectable only
by RT-PCR. Therefore, we believed it was more likely
that NFATp controlled cartilage cell differentiation at the
level of the adult mesenchymal progenitor cell. Recently,
Caplan and colleagues have described an in vitro pellet cul-
ture system whereby purified MSCs harvested from human
or rabbit bone marrow can be differentiated along a chon-
drogenic or osteogenic lineage (39–41, 43). For chondro-
genesis, such cultures rely on the addition of TGF-b and the
morphometric constraints of a pellet culture system. The
expression of NFAT family members was assessed in hu-
man MSCs cultured under chondrogenic conditions (Fig. 4).
In bone marrow–derived stem cells untreated with exoge-
nous growth factors, so-called “control,” NFATp transcripts
were detectable. By day 3 of differentiation, NFATp mRNA
levels had markedly increased in stem cells cultured under
chondrogenic conditions, and by day 14, NFATp transcripts
had further increased. In contrast, in stem cells cultured un-
der osteogenic conditions, transcripts for NFATp were not
detectable. Thus, levels of NFATp are specifically regulated
during chondrogenesis. Transcripts for the three other NFAT
family members, NFATc, NFAT4, and NFAT3, were also
present in differentiating chondrocytes. However, in con-
trast to NFATp, their level of expression did not fluctuate
during differentiation and was not restricted to the chondro-
genic pathway, as they were also detected in cultures differ-
entiated along an osteogenic pathway (not shown). We
conclude from these data and from the in vivo phenotype
described above that NFATp expression is regulated in un-
differentiated human MSCs during chondrogenesis, and that
NFATp is the family member likely to control lineage
commitment along this pathway in postembryonic MSCs.
NFATp2/2 Cartilage Cells Have Increased Expression of Car-
tilage Markers, Whereas Ectopic Expression of NFATp in Two
NFATp2/2 Cartilage Cell Lines Derived from Both Articular and
Extraarticular Tissues Extinguishes the Cartilage Phenotype. The
uncontrolled proliferation of resident connective tissue cells
and their differentiation to cartilage cells and the prolifera-
tion of existing articular cartilage cells, coupled with the
regulated expression of NFATp in MSC cultures, suggested
that NFATp represses the chondrogenic program. To fur-
ther investigate this possibility, we took two approaches. First,
we compared the levels of transcripts for type II and X col-
lagen by semiquantitative RT-PCR in primary articular
chondrocytes established from wt and NFATp2/2 femoral
heads. Fig. 5 A demonstrates that articular chondrocytes
lacking NFATp have much higher (at least eightfold) levels
of both type II and X collagen mRNA than wt articular
cartilage cells.
Second, we stably reintroduced NFATp into S12 and
EA, two cartilage cell lines derived from bulk-cultured
NFATp2/2 articular cartilage and extraarticular cartilage,
respectively. Several transfected subcloned S12 lines and
bulk-transfected but not subcloned EA lines were derived
and analyzed by Western blot for expression of NFATp
(Fig. 5 B). A panel of S12 and EA transfectants expressing
different levels of NFATp were then analyzed by semi-
quantitative RT-PCR for expression of characteristic carti-
lage cell markers (Fig. 5 C). Expression of type II collagen,
type X collagen, and CDMP-1 were markedly repressed in
all of the S12 NFATp transfected sublines, and a correla-
tion between levels of NFATp protein and repression of
cartilage cell phenotype was observed. In two of the three
bulk-transfected EA cells, overexpression of NFATp simi-
larly extinguished expression of the type II and type X col-
lagen genes compared with two of the three control vector
(Rep) transfectants. The third line (EA.NFAT3) did not show
repression of the cartilage phenotype, whereas the third
control line (EA.Rep3) did. Therefore, we conclude that
the level of expression of NFATp in most instances con-
trols the extent to which a cell manifests a cartilage pheno-
type, as determined by expression of markers characteristic
of differentiated cartilage.
NFATp Has the Features of a Murine Tumor Suppressor
Gene. Several pieces of data suggest that the proliferating
cartilage cells in NFATp-deficient animals may sometimes
undergo transformation. First, the proliferating cartilage cells
both in articular cartilage (Fig. 6 D) and in the extraarticu-
lar soft tissues (Fig. 6, E and F) varied in size but were usu-
ally very large, had increased chromatin content, noticeable
mitotic figures, and were safranin O positive (Fig. 6, D–F).
Cells with multiple nucleoli were observed (Fig. 6, E and F).
Further, this uncontrolled formation of extraarticular carti-
lage and bone often invaded and extended beyond the con-
nective tissues, progressing between the overlying muscle
fibers (Fig. 6, A–C). This cytogenetic picture coupled with
the invasion of the acetabulum by proliferating cartilage cells
in the ligamentum teres (Fig. 6, A–C) strongly suggested a
malignant process, likely accounting for the destruction of
the joint in the older animals. Second, in contrast to the slow
Figure 4. Expression of NFATp
is regulated during chondrogen-
esis. Northern blot analysis of
human MSCs undifferentiated or
differentiated under chondro-
genic (top) or osteogenic (bottom)
conditions. Expression of NFATp
and actin was determined.15 Ranger et al.
growth of cartilage cells observed in cultures established
from wt and heterozygous mice, some of the cultures es-
tablished from both the articular and extraarticular sites from
NFATp2/2 mice expanded rapidly, necessitating frequent
passaging. Thus, in contrast to wt cartilage cells, NFATp2/2
cartilage cells did not display contact-induced growth inhi-
bition since they continued to proliferate in vitro even when
plated at confluency (Fig. 7). Third, karyotypic analysis of
Figure 5. Absence of NFATp enhances, whereas overexpression of NFATp represses the cartilage phenotype. (A) RT-PCR analysis of mature carti-
lage gene expression in primary wt and NFATp2/2 articular chondrocytes using types II and X collagen and HPRT primers. (B) Western blot analysis of
S12 and EA control (Rep) and NFATp transfectants with anti-NFATp antibody. (C) RT-PCR analysis of mature cartilage gene expression of S12 and
EA control and NFATp transfectants using type II collagen, type X collagen, CDMP-1, and actin primers (references 36–38).16 NFATp Represses Chondrogenesis
four cartilage cell lines (one male, three female) established
from NFATp2/2 mice revealed aneuploidy in the three fe-
male lines, although there were no consistent karyotypic
abnormalities observed (Table I). The histologic phenotype,
coupled with the loss of contact inhibition and the pres-
ence of aneuploidy, suggests that the cartilage cells arising
in NFATp-deficient mice may occasionally undergo trans-
formation to a malignant state. Thus, some of the cartilage
tumors in the NFATp2/2 mice may be best classified as
chondrosarcomas even though a pathologic survey of lungs,
brain, and intestine did not reveal metastatic lesions. How-
ever, spontaneous solid tumors in mice rarely metastasize.
It should be noted also that NFATp2/2 cartilage cells do
retain a differentiated phenotype similar to some, but not
all, human chondrosarcomas (“low grade”).
Discussion
The NFATp Transcription Factor Is a Regulator of Chondro-
genesis. Levels of NFATp control cartilage cell induction and
proliferation, resulting in a spectrum of growth abnormalities
ranging from hyperproliferation to neoplastic transformation,
although the mechanism by which NFATp inhibits cartilage
cell growth and differentiation is not understood. Few mo-
lecular regulators of chondrogenesis are known, and most of
these operate during skeletal morphogenesis rather than in
the adult animal. Our studies demonstrate that a member of
the NFAT family of transcription factors, NFATp, appears
to be a repressor of cartilage cell growth and differentiation
in the adult animal. Further, the uncontrolled induction
and proliferation of cartilage cells that result from its ab-
sence presumably increase the likelihood of a “second-hit”
that then can result in frank transformation of these cells.
Figure 6. Transformation of and invasion by NFATp2/2 cartilage cells. (A) Extraarticular connective tissues of 6-mo-old NFATp2/2 mouse showing
invasion and differentiation of cartilage cells into muscle. Primitive transformed proliferating cells show early differentiation into chondroblasts (arrows);
original magnification: 3100. (B) High power (original magnification: 3200) of A, showing columns of primitive transformed cells differentiating into
prechondroblasts. (C) High power (original magnification: 3200) of 1-yr-old NFATp2/2 mouse showing cartilage cells invading muscle (arrows). (D)
High power (original magnification: 3400) of articular cartilage of 1-yr-old NFATp2/2 mouse showing abnormal-looking cartilage cells with multiple
nuclei (arrows). Note the normal appearance of the layer of calcified cartilage. (E) High power (original magnification: 3400) of extraarticular cartilage
cells from 1-yr-old NFATp2/2 mouse showing multiple cells in clusters (arrows). (F) Same as E, showing multiple nucleoli (arrows); original magnifica-
tion: 3400. m, muscle; c, cartilage cells; cc, calcified cartilage; ob, osteoblasts; b, bone.
Figure 7. NFATp2/2 cartilage cells show loss of contact-induced
growth inhibition. Varying numbers of wt or NFATp2/2 cartilage cells
were plated, and cell division was monitored. Cell division continued
even in cells that had reached confluency.17 Ranger et al.
To our knowledge, NFATp is the first transcription factor
to be identified that controls the induction of chondrogen-
esis from adult connective tissue progenitor cells. There are
three other known members of the NFAT family, all of
which are expressed in cartilage. Although all four known
NFAT family members are present in cartilage cells, only
the expression of NFATp is regulated during the process of
chondrogenesis. Further, only the expression of NFATp and
not NFATc, NFAT4, or NFAT3 was restricted to MSCs
undergoing chondrogenesis rather than osteogenesis. We
conclude that NFATp is the member of this family in-
volved in regulating the chondrogenic program, but it will
be of interest to carefully examine cartilage morphology in
mice lacking other members of the NFAT family.
NFATp Regulates Chondrogenesis in the Adult Animal.
Consistent with the normal skeletal development of mice
lacking NFATp, we did not detect NFATp expression in
cartilage during embryogenesis. Rather, our data implicate
NFATp as a critical regulator of chondrogenesis in the adult
animal. Thus, NFATp expression is specifically regulated in
human adult MSCs during in vitro chondrogenesis, whereas
overexpression of NFATp represses the mature cartilage
phenotype.
This is in contrast to the function of the cartilage-specific
transcription factor, Sox9, which is critical in cartilage mor-
phogenesis (48). Mutations in the Sox9 gene or in the Sox9
promoter are responsible for the human disease campo-
melic dysplasia (49, 50). Several additional regulators of
chondrogenesis during embryonic development have been
identified (51–53). Analysis of mutant mice has provided
evidence for a role in cartilage development and differenti-
ation for Indian Hedgehog (54, 55), parathyroid hormone–
related protein (PTHrP [54, 56, 57]), fibroblast growth fac-
tors (58–60), insulin-like growth factors (61), Noggin (62),
and BMPs, a family of secreted signaling molecules origi-
nally isolated by virtue of their ability to induce ectopic
cartilage and endochondral bone formation when implanted
into subcutaneous tissues of adult animals (46, 47, 55, 63–66).
It is unlikely that NFATp acts through controlling these
known regulators of chondrogenesis, since these appear to
play a more important function in morphogenesis affecting
both skeletal and nonskeletal organ systems than they do in
controlling growth of adult cartilage cells. For example, the
mouse short ear mutation is secondary to inactivation of the
BMP5 gene (47), whereas mutations of the GDF5 gene ac-
count for limb alterations in brachypodism mice (67). Indian
Hedgehog is expressed in prehypertrophic chondrocytes
where it controls the rate of hypertrophic differentiation in
part through inducing the expression of a second signal,
PTHrP, in the perichondrium. PTHrP2/2 mice have de-
fects in formation of hypertrophic cartilage (54, 57). In-
deed, we found no evidence that NFATp directly regulated
the transcription of several members of the BMP family or
the TGF-b proteins themselves or acted through a secreted
factor. Rather, the dysregulation of cartilage growth ap-
peared to be cell intrinsic. However, it is of interest that
NFATc and the type III TGF-b receptor are both required
for endocardial cell transformation in the heart (5, 6, 68),
raising the possibility that signal transduction pathways stem-
ming from TGF-b receptors intersect with NFAT proteins.
We speculate that initiation of chondrogenesis results in
activation of NFATp, which then sets in motion a genetic
program to control cartilage differentiation and prolifera-
tion. Presumably, NFATp-regulated genes in cartilage must
act in part to repress this program, since overexpression of
NFATp extinguished the differentiated cartilage phenotype
while loss of NFATp resulted in spontaneous activation of
chondrogenesis. Future experiments will focus on identify-
ing the upstream targets and downstream effectors of NFATp
both in the MSC and in mature articular cartilage. One can
speculate that some of the NFATp-regulated genes in MSCs
will control proliferation, as evidenced by the uncontrolled
division of these cells in its absence. Some of these may well
be modifiers of NFATp activity that can account for the
substantial sex difference in the development of the pheno-
type. In contrast to the complete penetrance (100%) of the
cartilage phenotype in female mice, only approximately one
third of male mice is affected, and the onset of symptoms is
later. There is much precedent for gender differences in
diseases: systemic lupus erythematosus, rheumatoid arthri-
tis, and ankylosing spondylitis are well-known examples. A
reasonable guess is that female or male sex hormones are
involved in the phenotype described here because of direct
or indirect regulation by NFATp.
Table I. Cytogenetic Analysis of NFATp2/2 Cartilage Cell Lines
Tumor Karyotype
1 40,XY
2 40–41,XX[cp7]/39–40,xx-4[6],-12[7],117[2],
1mar[5][cp7]/43,X,der(?X),add(1),der(?6),1?7,
19,1mar5[3]
3 40,X-X,1mar[3]/39,X-X,-14,1mar[2]/41,
XX1mar[4]/40,XX[41]
4 71–89,XXXX-2[6],-3[10],-4[12],-4[10],-6[2],
-7[8],-9[6],-10[2],-11[4],-12[3],-13[2],-14[3],
-15[2],-16[2],-17[2],118[4],11-6mar[9][cp12]
Aneuploidy in NFATp2/2 tumor cells. Karyotypic analysis of four
tumor cell lines from NFATp2/2 mice revealed aneuploidy in three of
them. The first line was a normal male with random chromosome loss.
The second line had a modal chromosome no. of 40 in 7 cells with
monosomy of chromosomes 4 and 12, trisomy of chromosome 17, and
gain of markers in most of the cells. An additional three cells displayed
additional structures and numerical abnormalities. 2 clones were
observed in the third tumor, a normal 40XX clone in 41 cells, and an
abnormal clone that demonstrated clonal evolution. A marker
chromosome was observed in all cells in the clone, and in addition, five
cells demonstrated loss of an X and two of these also had loss of
chromosome 14. The fourth tumor, derived from extraarticular
cartilage, was pseudotetrapoid with a modal chromosome no. of 71–76
(range 71–89), with a consistent finding of loss of chromosomes 4 and
16. One to six marker chromosomes were observed in most cells, and
there were no normal diploid or tetraploid cells. mar, marker; der,
derivative; add, additional material of unidentified origin.18 NFATp Represses Chondrogenesis
NFATp Controls Differentiation of MSCs into Cartilage.
NFATp acts as a repressor of cartilage cell differentiation
from primitive MSCs, since in its absence, cartilage cells,
many of which undergo the endochondral sequence of os-
sification, are induced to form and proliferate in the sur-
rounding extraarticular connective tissues. Thus, the devel-
opmental sequence of endochondral bone formation is
recapitulated in the absence of NFATp. It has been difficult
to recapitulate the process of chondrogenesis from stem
cells in vitro, although there has been some recent success
in doing so under very stringent culture conditions (39–41,
43). It will be interesting to determine whether NFATp2/2
MSCs derived from mice that also express an SV40 T anti-
gen transgene (H-2Kb-tsA58 “immortomouse” [44, 69]) will
spontaneously differentiate into cartilage in vitro. In this re-
gard, the effect of the NFAT inhibitors, CsA and FK506, on
in vitro chondrogenesis from wt MSCs will be interesting
to establish. Given the extremely low level of NFATp ex-
pression in mature cartilage cells, we suspect that the prolif-
eration of articular cartilage cells observed is secondary to
recruitment of MSCs or stem cells that reside in synovial
lining tissue to this site. MSC recruitment, their differentia-
tion into chondrocytes, and their mitotic expansion at dif-
ferent stages of commitment are all separable activities that
could be affected by NFATp. Compounds that block the
function of NFATp in cartilage may prove valuable in
achieving sustained differentiation and growth of cartilage
from MSCs in vitro or in vivo. Such inhibitors might con-
trol MSC recruitment and chondrogenesis in response to
environmental injuries such as occur during normal me-
chanical wear and tear. The potential use of such NFATp
inhibitors in degenerative joint diseases such as osteoarthri-
tis, where cartilage has been destroyed, as well as in the
stimulation of endochondral bone formation to repair bone
defects and fractures in which endochondral bone forma-
tion plays an important role, is obvious.
NFATp May Act as a Tumor Suppressor in Cartilage. We
show here that NFATp displays properties of a tumor sup-
pressor gene in cartilage, as evidenced by the neoplastic
changes in NFATp2/2 cells in both articular cartilage and
extraarticular cartilage. The invasive nature of the cartilage
cell proliferation in vivo, coupled with their behavior in
vitro and ability to form tumors in syngeneic mice (Gersten-
feld, L.C., unpublished observations), suggests that these are
chondrosarcomas. There has been controversy about what
constitutes malignancy in cartilage tumors in humans (70).
Chondrosarcomas are second only to osteosarcomas as the
most frequent primary malignant tumors of bone (70, 71).
Unlike osteosarcoma or Ewing’s sarcoma, chondrosarcomas
are minimally responsive to chemotherapy and are largely
treated by surgical excision. Outcome is difficult to predict
in part because chondrosarcomas are difficult to grade and
can be confused with benign enchondroma or osteocarti-
laginous exostosis (70, 71). This has recently prompted the
use of other methods of assessing tumor virulence such as
imaging, mean DNA content, and presence of aneuploidy
to help predict outcome (72, 73). Although a variety of
chromosomal abnormalities has been noted in human
chondrosarcomas, including loss of heterozygosity at the
EXT1 locus (74, 75), no consistent cytogenetic phenotype
has been described, similar to what was observed in the
NFATp2/2 tumor lines. Unlike osteosarcoma and Ewing’s
sarcoma, which almost always involve mutations in the Rb
(76) and EWS1 (Ewing’s sarcoma) genes, no frequent asso-
ciation with known tumor suppressor genes has been re-
ported for chondrosarcomas, although abnormalities in p53
expression have been reported (77, 78). In preliminary ex-
periments, we have not detected abnormalities in p53 ex-
pression, but it will be important to analyze the NFATp2/2
transformed cell lines presented here for mutations in other
known tumor suppressor genes. Further, since almost no
transformed, differentiated, rapidly growing, and transfect-
able cartilage cell lines are available, these cell lines should
prove very valuable for the analysis of gene regulation and
function in cartilage. Finally, our data suggest that a careful
examination of human chondrosarcoma tissue for the pres-
ence of NFATp gene mutations may be warranted.
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